• Pomalyst


Facts of Pomalyst (Pomalidomide) Capsules ?

  • Medicine Name: Pomalyst
  • Generic Name: Pomalidomide
  • Approval Date: February 8, 2013
  • Company Name: Celgene Corporation
  • Available as (Form & Strength): Capsules: 1 mg, 2 mg, 3 mg, and 4 mg

Product Description

What are the indications and usage?

POMALYST is a thalidomide analogue indicated, in combination with dexamethasone, for patients with multiple myeloma who have received at least two prior therapies including le nalidomide and a proteasome inhibitor and have demonstrated disease pr ogression on or within 60 days of completion of the last therapy

How supplied/storage and handling ?

Store at 20°C-25°C (68°F-77°F); excursions permitted to 15°C-30°C (59°F-86°F).


There are no reviews yet.

Be the first to review “Pomalyst”